SLC2A14 and cancer: Although the present results need to be corroborated by more research with larger sample sizes, these findings indicate that these SNPs in the ANGPT1 and SLC2A14 genes could serve as markers that predict the efficacy of opioid analgesics in the treatment of cancer pain.